IAS 2015: International AIDS Society Conference Starts this Weekend in Vancouver
- Details
- Category: HIV Treatment
- Created on Thursday, 16 July 2015 00:00
The 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015) starts this Sunday and runs July 19-22 in Vancouver. HIV prevention -- including treatment-as-prevention and pre-exposure prophylaxis (PrEP) -- will be a major focus of the meeting. Other topics will include antiretroviral drugs in development, expanding access to treatment and retention in care, and HIV/hepatitis coinfection. HIVandHepatitis.com will be on site covering the latest news.
HIV and Hepatitis C Highlights from AIDS 2014
- Details
- Category: HIV Treatment
- Created on Wednesday, 22 October 2014 00:00
Latest Positive Pulse Newsletter
Paul Sax from Harvard Medical School and Mark Sulkowski from Johns Hopkins School of Medicine discuss highlights from this summer's International AIDS Conference, the largest and most comprehensive global meeting on the medical, public health, and social aspects of HIV and AIDS.
Highlights of this overview include the HIV cascade of care, developments in antiretroviral therapy, pre-exposure prophylaxis (PrEP) and other HIV prevention news, and new hepatitis C treatment for people with HIV/HCV coinfection.
10/22/14
AIDS 2014: What Is Needed to "Step Up the Pace" on HIV Prevention and Treatment?
- Details
- Category: HIV Treatment
- Created on Thursday, 07 August 2014 00:00
"Stepping up the pace" -- the theme of AIDS 2014 -- will require a new focus on key populations and geographical concentrations of HIV, as well as intensified efforts to expand coverage of HIV testing and treatment, according to Prof. Salim Abdool Karim, director of CAPRISA, who reviewed the global state of the epidemic and treatment access at the 20th International AIDS Conference held recently in Melbourne.
AIDS 2014: Low Level Viral Load Does Not Raise Risk of HIV Treatment Failure
- Details
- Category: HIV Treatment
- Created on Thursday, 04 September 2014 00:00
People with HIV who have a low-level viral load between 20 and 50 copies/mL were not more likely to experience virological failure of antiretroviral therapy (ART) compared with those who consistently maintained viral suppression below 20 copies/mL, according to research presented at the 20th International AIDS Conference in Melbourne.
Of Guidelines Targets, and Resources -- Documents that Defined AIDS 2014
- Details
- Category: HIV Treatment
- Created on Tuesday, 29 July 2014 00:00
If there was a phrase that defined the 20th International AIDS Conference last week in Melbourne -- one that surfaced in every few presentations and kept turning up in documents -- it was "key affected populations." New World Health Organization (WHO) guidelines released in conjunction with AIDS 2014 recommend pre-exposure prophylaxis (PrEP) as an option for gay men at risk for HIV infection and naloxone to prevent overdoses among people who inject drugs (PWID).
More Articles...
- AIDS 2014 Conference Highlight from Sharon Lewin [VIDEO]
- Coverage of the 2014 International AIDS Conference
- AIDS 2014: Law and Policy Must Be Part of the Solution for AIDS [VIDEO]
- TAG Releases 2014 HIV, Hepatitis C, and Tuberculosis Pipeline Report
- AIDS 2014: Criminalization Fuels HIV/AIDS Epidemic [VIDEO]
- In Memorium: AIDS 2014 Delegates Lost in Malaysian Airlines Crash
- AIDS 2014: International AIDS Conference Starts Sunday in Melbourne
- AIDS 2014: Single-tablet HIV Regimens Not Necessarily More Durable
- AIDS 2014: Switching ART with Suppressed Viral Load Linked to Treatment Failure
- AIDS 2014: Dolutegravir Demonstrates Good Efficacy Despite Resistance
- AIDS 2014: Maraviroc Fails To Match Truvada for First-Line HIV Treatment
- AIDS 2014: Australian Bone Marrow Transplant Patients Show No Detectable HIV
- AIDS 2014: Novel Techniques Probed in HIV Cure Research
- AIDS 2014: Disappointing HIV Cure News Leads to New Questions
- AIDS 2014: Researchers Discuss Progress Towards an HIV Cure [VIDEO]
- AIDS 2014: Romidepsin Activates Latent HIV, But Does Not Decrease Viral Reservoir
- HIV Cure Is a Major Priority, Research to be Presented at AIDS 2014
- AIDS 2014: Most Gay Men Who Don’t Use Condoms Attempt to Reduce HIV Risk
- Counseling Helps Improve PrEP Adherence Among Serodiscordant Couples
- AIDS 2014: Female Condoms for HIV Prevention [VIDEO]
- AIDS 2014: HIV Prevention for Gay Men Differs Between San Francisco and London
- AIDS 2014: Studies Show Need for Scaled-up HIV Prevention for Sex Workers
- AIDS 2014: WHO Guidelines Recommend PrEP as Prevention Option for Gay Men [VIDEO]
- AIDS 2014: iPrEx PrEP Users Talk Condoms, Pills, Anxiety, and Relief
- AIDS 2014: Good Adherence Seen in IPERGAY Study of Intermittent PrEP
- AIDS 2014: iPrEx OLE Confirms PrEP Works, but Many Don't Take It [VIDEO]
- AIDS 2014: iPrEx OLE Shows PrEP Effectiveness Is 100% for Those Taking 4 or More Doses per Week
- AIDS 2014: Only Half of People Who Start HIV Post-exposure Prophylaxis Complete the Course
- AIDS 2014: Circumcised Men and Female Partners Have Lower Syphilis Rates
- AIDS 2014: Adult Male Circumcision Also Protects Women from HIV Infection [VIDEO]
- AIDS 2014: COPD Is Common Among People with HIV Even At High CD4 Counts
- AIDS 2014: Weight Gain on ART May Raise Risk of Heart Disease and Diabetes
- AIDS2014: Efavirenz Use Not Linked to Neurocognitive Impairment, Study Finds
- AIDS 2014: Anal Lesions Often Resolve Without Treatment In HIV Positive Gay Men
- UNAIDS Gap Report Finds Half of HIV+ People Worldwide Are Unaware of Status
- AIDS 2014: More Data Suggest Increased HIV Risk from Injectable Contraceptives
- AIDS 2014: Mothers Starting Option B+ ART in Malawi Often Lost from Care
- AIDS 2014: Increased ART for Mothers Does Not Guarantee Optimal Care for Infants
- AIDS 2014: Worldwide Adolescent AIDS Deaths Rising, Especially Among Boys
- AIDS 2014: Harm Reduction Funding Is Meeting Only 7% of Global Need
- AIDS 2014: Criminalization of Sex Work Increases Vulnerability to HIV
- AIDS 2014: People with HIV -- Not Victims But Partners [VIDEO]
- AIDS 2014: Melbourne Declaration -- Nobody Left Behind
- AIDS 2014 Mobilization: Activists Demand More HIV Funding, End Stigma [VIDEO]
- AIDS 2014: Positively Fabulous Aims to Change HIV+ Women's Lives [VIDEO]
- AIDS 2014: No One Left Behind in Response to HIV/AIDS [VIDEO]
- AIDS 2014: Global ART Demand Projected to Reach 16.8 Million by 2016
- AIDS 2014: Criminalization Decreases HIV Prevention and Treatment Among Gay Men [VIDEO]
- AIDS 2014: Police Can Play a Role in Reducing HIV [VIDEO]
- July 28 Is World Hepatitis Day [VIDEO]
- AIDS 2014: AbbVie Hepatitis C Treatment Works Well for People on Methadone or Buprenorphine
- AIDS 2014: HIV/HCV Coinfected Have High Cure Rates with Interferon-free Hep C Combos
- AIDS 2014: AbbVie 3D Regimen Cures Most Genotype 1 HIV/HCV Coinfected Patients
- AIDS 2014: Sofosbuvir + Ribavirin Cures More Than 80% of HIV/HCV Coinfected People
- AIDS 2014: Novel PaMZ Tuberculosis Regimen Could Reduce Treatment Duration
- AIDS 2014: Young People with HIV Respond Well to Human Papillomavirus Vaccine
- 14. HIV Researchers and Advocates Killed in Plane Crash En Route to AIDS Conference